Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression [Phase 3]
Phase 3 trial update evaluating a selegiline transdermal system for safety, tolerability and efficacy in elderly patients with major depress…
-
FDA approval · 2008-04-17FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine by Teva Pharmaceuticals USA, Inc. The approval updates the product labeling and/o…
-
FDA approval · 2008-04-14FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Aurobindo Pharma Limited, indicating regulatory clearance for a…
-
FDA approval · 2008-04-14FDA Approved: AMOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Amoxapine by Actavis Pharma, Inc. The submission status indicates approval (AP).
-
CLINICAL_TRIALS trial_result · 2008-04-09Clinical Trial Update: Efficacy and Safety of Antidepressant Augmentation With Lamotrigine [Phase 3]
Phase 3 trial evaluating the efficacy and safety of antidepressant augmentation with lamotrigine in patients with major depressive disorder.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-04-03FDA Approved: CITALOPRAM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Citalopram from Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2008-04-03Clinical Trial Update: Parent Psychoeducation and Cognitive Behavior Therapy for Latino Adolescents With Depression [Phase 2]
This entry reports a Phase 2 clinical trial evaluating parent psychoeducation combined with cognitive-behavioral therapy for Latino adolesce…
-
CLINICAL_TRIALS trial_result · 2008-04-02Clinical Trial Update: Efficacy Study of Escitalopram for Depression in Patients With Diabetes [Phase 4]
Clinical trial update on the efficacy of escitalopram for major depressive disorder in patients with diabetes (Phase 4). Current status of t…
-
CLINICAL_TRIALS trial_result · 2008-03-31Clinical Trial Update: Safety Study of ORG 34517 for Major Depression With Psychotic Features [Phase 2]
A Phase 2 safety study evaluating ORG 34517 for major depressive disorder with psychotic features has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-26Clinical Trial Update: Self-Efficacy Enhancing Interviewing Techniques Study [NA]
A completed clinical trial from the University of California, Davis evaluating self-efficacy–enhancing interviewing techniques in patients w…
-
CLINICAL_TRIALS trial_result · 2008-03-24Clinical Trial Update: Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder [Phase 2]
A Phase 2 multicenter trial evaluating the safety and efficacy of CP-316,311 for Major depressive disorder has been terminated.
-
CLINICAL_TRIALS research · 2008-03-24Clinical Trial Update: Girls in Transition Study: Helping Girls Enter the Teenage Years [Phase 1]
Phase 1 clinical trial update on the Girls in Transition study addressing depression and anxiety in adolescent girls; the status is UNKNOWN.
-
CLINICAL_TRIALS research · 2008-03-24Clinical Trial Update: R4Power: An Online Resilience Program for Adolescents [Phase 1]
A Phase 1 clinical trial update for an online resilience program called R4Power targeting adolescents with depression and anxiety.
-
FDA approval · 2008-03-21FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2008-03-13FDA Approved: PAROXETINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic paroxetine product (paroxetine hydrochloride hemihydrate) from Mylan Pharmaceuticals Inc. under an original ANDA.
-
FDA approval · 2008-03-09FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS trial_result · 2008-03-07Clinical Trial Update: Acupuncture in the Treatment of Depression [Phase 3]
Phase 3 clinical trial update reporting the completion of a study evaluating acupuncture as a treatment for depression. The excerpt notes th…
-
CLINICAL_TRIALS trial_result · 2008-03-07Clinical Trial Update: Treatment of Depression With Massage in HIV [Phase 2]
Phase 2 clinical trial on using massage to treat depression in people with HIV/AIDS completed.
-
FDA approval · 2008-03-06FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride from Mylan Pharmaceuticals Inc., indicating approval of a supplemen…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment of Mid-Life-Related Mood Disorders [Phase 2]
Phase 2 clinical trial update from the National Institute of Mental Health on mid-life mood disorders. The study has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Riluzole to Treat Major Depression [Phase 2]
A Phase 2 trial evaluating riluzole for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Examination of a Soy-Based Supplement for Major Depression [Phase 2]
Phase 2 clinical trial evaluating a soy-based supplement for major depressive disorder has completed; no results are provided in the availab…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression [Phase 2]
A Phase 2 trial evaluating whether adding the 5-HT2A antagonist M100907 to citalopram improves outcomes in treatment-resistant depression; t…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Clinical Trial of Memantine for Major Depression [Phase 3]
A Phase 3 clinical trial evaluating memantine for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders
This completed trial evaluated the effect of gonadotropin-releasing hormone on pituitary hormones in menstrual-cycle mood-related disorders.…